AI has changed what’s possible. Systems trained on genomic databases spanning tens of thousands of sequenced cancer samples ...

The experimental therapy is designed to activate the immune system's ability to not only recognize and destroy cancer cells, ...

A lab in Hawaiʻi is developing nanobodies, tiny proteins that help the immune system recognize and destroy cancer cells, ...

Keytruda's first approval by US FDA came in the year 2014 for advanced skin cancer. Now, the immunotherapy drug is being used ...

Researchers at the Centro Nacional de Investigaciones Cardiovasculares Carlos III (CNIC) show that active mitochondria ...

Multiple myeloma is the second most common blood cancer in adults. It starts in the white blood cells that are responsible ...

In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.

A protein that helps cancer cells hide from the immune system may have a critical weakness, according to research that could ...

Mary Bird Perkins Cancer Center in Baton Rouge, Louisiana is offering a CAR-T cell-based immunotherapy, which genetically ...

Once built to fight cancer, CAR‑T therapy is now offering new hope for patients with severe autoimmune disease.

Scientists have discovered a way to supercharge the immune system’s T cells by blocking a protein called Ant2, forcing the cells to rewire how they generate energy. This shift makes them more powerful ...

Half were assigned to do a session of resistance training (think weight lifting), while the other half did a session of HIIT ...